Preliminary data show J&J vaccine could be effective against delta variant

Preliminary data show that Johnson & Johnson’s one-dose coronavirus vaccine could be effective against the delta variant (B.1.617.2) of the coronavirus. The company said in a statement that its vaccine demonstrated a “strong, persistent…